| [1] 谢欣,易韦,于燕妮,等.人脑胶质瘤相关基因的研究进展[J].中华临床医师杂志,2014,8(8):1543-1548.[2] Tania M,Khan MA,Zhang H,et al.Autotaxin:a protein with two faces[J].Biochem Biophys Res Commun,2010,401(4):493-497.[3] Kluza L,Lansiaux A,Wattez N,et al.Apoptotic response of HL-60 human leukemia cells to the anti-tumor drug TAS-103[J].Cancer Res,2000,60(15):4077-4081.[4] Cohen GM,Sun XM,Fearnhead H,et al.Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes[J].J Immunol,2009,153(2):507-509.[5] Nagaraja V.Regulation of DNA topology in mycobacteria[J].Current Sci,2004,86(1):135-140.[6] Drake PH,Sansano H,Yamaki H,et al.Biochemical and pharmacologica;properties of P170 and P180 isoforms of topoisomeraseⅡ[J].Biochemistry,2010,28(11):54-56.[7] Alexis L.Etoposide improves survival in high-grade glioma:a Meta-analysis[J].Anticancer Res, 2013,33(8):3307-3315.[8] 霍海波.MGMT、TopoⅡα、P-g p 在胶质瘤组织中的表达变化及意义[J].中华老年学杂志,2014,24(12):3303-3304.[9] Bravo R,Frank R,Blundell PA,et al.Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta[J].Nature,2011,326(6112):515-517.[10] Cunningham JM,Kimmel DW,Scheithauer BW,et al.Analysis of proliferation markers and p53 expression in gliomas of astrocytic organ:relationships and prognostic value[J].Neurosurgery,2008,86(1):121-130.[11] Barbareschi M.P53 protein expression in central nervous system neoplasm[J].Clin Pathal,2012,45(7):583-586.[12] 罗卫,刘晓燕,方永军,等.HSG/Mfn2和PCNA 在人脑胶质瘤组织中的表达及意义[J].实用癌症杂志,2014,29(3):266-268.[13] 甄云,严静玲,廉晓宇.增殖细胞核抗原及表皮生长因子受体表达与脑星形细胞瘤分级的相关性及意义[J].中国神经精神疾病杂志,2003,29(3):163-164.[14] Timothy J,Haggerty W.Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells[J].Cancer Immunol, 2011,60(1):133-144.[15] 郭国财,刘佳,薄勇力,等.齐墩果酸通过MAPK/ERK信号传导通路对U87 MG细胞增殖及凋亡的体外实验研究[J].中华神经外科杂志,2013,29(5):478-483.[16] 鲁润春,贾旺,姜文国.血脑屏障Claudin蛋白在脑转移瘤发生发展中的作用[J].中华神经外科杂志,2014,30(1):100-104.[17] 凌锋.介入神经放射学[M].北京:人民卫生出版社,1991:196-197.[18] 陈博年,吴剑涓.脑胶质瘤的药物治疗[J].天津药学,2011,23(1):58-62. |
